Pulling SEC filings + quote and writing the call…

Sintx Technologies, Inc.
Next earnings Aug 12, 2026 · consensus $-0.69 EPS, $415K rev
Last earnings -10.8% on 2025-11-13
Sub-$8M shell burning $8.6M/yr on $1M of shrinking revenue with ~6 months of cash — a serial diluter, not an investment.
Revenue $1.02M · FY2025
SINTX is a 30-year-old advanced-ceramics company that has never turned a profit and is now shrinking. FY2025 revenue fell 65% to $1.02M — the MD&A frames this as a 'strategic repositioning away from non-core, low-margin OEM' work, but the reality is that grant/contract revenue collapsed 82% ($1.64M→$0.29M) and even core product revenue fell 41%. Gross profit dropped 78% to $461K. Against that trickle of revenue sits an $11.2M operating-expense base ($4.59M R&D, $6.20M G&A), producing a -$10.7M operating loss and a -1053% operating margin. This is not a business with a temporary setback; five years of history (FY21–FY25 revenue $0.61M→$1.56M→$2.63M→$2.89M→$1.02M, never once profitable, cumulative deficit now -$292M) shows a company that cannot scale silicon nitride into a self-sustaining enterprise.
The balance sheet is the decisive problem. Operating cash flow was -$8.57M in FY2025 while cash stood at just $4.14M — roughly six months of runway at the current burn. The only way SINTX has stayed alive is by issuing stock: shares outstanding jumped 64% in a single year to 4.12M (post reverse-split math on a $1.90 quote), and equity still fell 25% to $2.93M despite that raise. Liabilities/equity climbed to 2.25x as current liabilities nearly doubled (+88%). A retail buyer today is almost certain to be diluted heavily — or wiped out in another reverse split — within the next few quarters simply to keep the lights on.
Is SINT a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $606K | $1.56M | $2.63M | $2.89M | $1.02M |
| Gross profit | $157K | $1.30M | $1.84M | $2.08M | $461K |
| Operating income | -$10.6M | -$11.3M | -$13.4M | -$14.0M | -$10.7M |
| Net income | -$9.31M | -$12.0M | -$8.26M | -$11.0M | -$10.4M |
| Diluted EPS | -$39.91 | -$60.81 | -$624.47 | -$15.19 | -$6.16 |
| Net margin | -1536.1% | -771.2% | -314.4% | -381.8% | -1018.1% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
New financing pact + unregistered share issuance — further dilution of tiny float
New shelf registration sets up more capital raises/dilution
Another securities agreement + unregistered equity sale; more dilution
Item 3.01: Nasdaq listing-deficiency notice — delisting risk
Q1'26 10-Q: continued operating losses, cash burn on $4M cash base
FY25: revenue -65% to $1.0M, -$10.4M loss; strategic repositioning
Officer/director change (Item 5.02); no financial impact disclosed
Amended shelf — advances dilutive capacity toward effectiveness
Reg FD investor/business update (Item 7.01), furnished not filed
Sources: SEC EDGAR (CIK 0001269026, latest 10-Q filed 2026-05-15) · EODHD · Proprietary analysis · as of 7/4/2026, 5:30:34 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 1:30 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-04-13 | Elmore Robert Ryan President | Award | 4.91K @ $2.89 | $14.2K |
| 2026-03-02 | Lyons Christopher Michael Director | Buy | 7.53K @ $2.90 | $21.8K |
| 2026-02-25 | Lyons Christopher Michael Director | Buy | 758.00 @ $2.96 | $2.24K |
| 2026-02-23 | MOYES JAY M Director | Buy | 1.00K @ $2.91 | $2.91K |
| 2026-02-18 | Anderson Mark Lewis Director | Buy | 3.00K @ $3.02 | $9.06K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median